Cyclic Multifunctional Linkers for Controlled Therapeutic Release

The patent combines multiple stimuli-responsive elements (pH-sensitive, enzyme-sensitive, redox-sensitive groups) within a single encapsulation system. The material requires simultaneous presence of multiple disease-associated stimuli (e.g., low pH + high MMP activity + reducing conditions) to trigger therapeutic release, merging several detection functions into one integrated platform that achieves high specificity for tumor microenvironments while avoiding off-target release in healthy tissues.

The invention creates composite smart materials that integrate multiple functional groups with different stimulus responses into a unified encapsulation system. These composite materials contain pH-sensitive moieties, enzyme-cleavable peptide sequences, and redox-sensitive disulfide bonds working together, allowing the system to distinguish tumor microenvironment conditions from normal physiological conditions and release therapeutics only at the target site.

The patent merges multiple degradation triggers into a single hydrogel system. The hydrogel contains crosslinks that are sensitive to pH changes, enzyme cleavage, and redox conditions simultaneously. The gel structure remains stable until all three stimuli are present together, at which point coordinated degradation occurs, providing both ease of controlled release and high specificity for the tumor microenvironment where all three conditions coexist.

The hydrogel is segmented into multiple functional domains with different stimulus responses. Each domain contains specific cleavable bonds (pH-labile bonds, enzyme-sensitive peptide bonds, redox-sensitive disulfide bonds) that respond to different stimuli. This segmentation allows the system to process multiple environmental cues independently and integrate their signals, achieving precise spatiotemporal control over therapeutic release with high specificity.